{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:23:22Z","timestamp":1792423402113,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T00:00:00Z","timestamp":1431475200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1395-6","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T17:06:07Z","timestamp":1431536767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma\u2014a suitable treatment option: case report and review of anti-angiogenic treatment options"],"prefix":"10.1186","volume":"15","author":[{"given":"Valeriya","family":"Semenisty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Naroditsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohar","family":"Keidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Bar-Sela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,13]]},"reference":[{"key":"1395_CR1","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/1097-0142(19830201)51:3<452::AID-CNCR2820510317>3.0.CO;2-M","volume":"51","author":"DH Dail","year":"1983","unstructured":"Dail DH, Liebow AA, Gmelich JT, Friedman PJ, Miyai K, Myer W, et al. Intravascular, bronchiolar, and alveolar tumor of the lung (IVBAT). An analysis of twenty cases of a peculiar sclerosing endothelial tumor. Cancer. 1983;51:452\u201364.","journal-title":"Cancer"},{"key":"1395_CR2","first-page":"259","volume":"3","author":"SW Weiss","year":"1986","unstructured":"Weiss SW, Ishak KG, Sweet DE, Enzinger FM. Epithelioid hemangioendothelioma and related lesions. Semin Diagn Pathol. 1986;3:259\u201387.","journal-title":"Semin Diagn Pathol"},{"key":"1395_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0046-8177(90)90131-N","volume":"21","author":"MH Gray","year":"1990","unstructured":"Gray MH, Rosenberg AE, Dickersin GR, Bhan AK. Cytokeratin expression in epithelioid vascular neoplasms. Hum Pathol. 1990;21:212\u20137.","journal-title":"Hum Pathol"},{"key":"1395_CR4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/j.1440-1843.2006.00923.x","volume":"11","author":"RM Amin","year":"2006","unstructured":"Amin RM, Hiroshima K, Kokubo T, Nishikawa M, Narita M, Kuroki M, et al. Risk factors and independent predictors of survival in patients with pulmonary epithelioid haemangioendothelioma. Review of the literature and a case report. Respirology. 2006;11:818\u201325.","journal-title":"Respirology"},{"key":"1395_CR5","first-page":"676","volume":"13","author":"D Rosengarten","year":"2011","unstructured":"Rosengarten D, Kramer M, Amir G, Fuks L, Berkman N. Pulmonary epithelioid haemangioendothelioma. Isr Med Assoc J. 2011;13:676\u20139.","journal-title":"Isr Med Assoc J"},{"key":"1395_CR6","first-page":"133","volume":"9","author":"S Gaur","year":"2012","unstructured":"Gaur S, Torabi A, O\u2019Neill TJ. Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report. Cancer Biol Med. 2012;9:133\u20136.","journal-title":"Cancer Biol Med"},{"key":"1395_CR7","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1183\/09031936.95.08091616","volume":"8","author":"ME Van Kasteren","year":"1995","unstructured":"Van Kasteren ME, Van der Wurff AA, Palmen FM, Dolman A, Misere JF. Epithelioid haemangioendothelioma of the lung: clinical and pathological pitfalls. Eur Respir J. 1995;8:1616\u20139.","journal-title":"Eur Respir J"},{"key":"1395_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/00000478-198109000-00008","volume":"5","author":"N Azumi","year":"1981","unstructured":"Azumi N, Churg A. Intravascular and sclerosing bronchioloalveolar tumor. A pulmonary sarcoma of probable vascular origin. Am J Surg Pathol. 1981;5:587\u201396.","journal-title":"Am J Surg Pathol"},{"key":"1395_CR9","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3892\/ol.2013.1217","volume":"5","author":"B Ye","year":"2013","unstructured":"Ye B, Li W, Feng J, Shi JX, Chen Y, Han BH. Treatment of pulmonary epithelioid hemangioendothelioma with combination chemotherapy: report of three cases and review of the literature. Oncol Lett. 2013;5:1491\u20136.","journal-title":"Oncol Lett"},{"key":"1395_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1378\/chest.111.1.236","volume":"111","author":"JJ Erasmus","year":"1997","unstructured":"Erasmus JJ, McAdams HP, Carraway MS. A 63-year-old woman with weight loss and multiple lung nodules. Chest. 1997;111:236\u20138.","journal-title":"Chest"},{"key":"1395_CR11","first-page":"898","volume":"121","author":"C Roudier-Pujol","year":"1994","unstructured":"Roudier-Pujol C, Enjolras O, Lacronique J, Guillemette J, Herbreteau D, Leibowitch M, et al. Multifocal epithelioid hemangioendothelioma with partial remission after interferon alfa-2a treatment. Ann Dermatol Venereol. 1994;121:898\u2013904.","journal-title":"Ann Dermatol Venereol"},{"key":"1395_CR12","first-page":"281","volume":"76","author":"E Radzikowska","year":"2008","unstructured":"Radzikowska E, Szczepulska-Wojcik E, Chabowski M, Oniszh K, Langfort R, Roszkowski K. Pulmonary epithelioid haemangioendothelioma\u2013interferon 2-alpha treatment\u2013case report. Pneumonol Alergol Pol. 2008;76:281\u20135.","journal-title":"Pneumonol Alergol Pol"},{"key":"1395_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1075-122X.2005.21663.x","volume":"11","author":"W Marsh Rde","year":"2005","unstructured":"Marsh Rde W, Walker MH, Jacob G, Liu C. Breast implants as a possible etiology of epithelioid hemangioendothelioma and successful therapy with interferon-alpha2. Breast J. 2005;11:257\u201361.","journal-title":"Breast J"},{"key":"1395_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/0973-1482.110386","volume":"9","author":"L Demir","year":"2013","unstructured":"Demir L, Can A, Oztop R, Dirican A, Bayoglu V, Akyol M, et al. Malignant epithelioid haemangioendothelioma progressing after chemotherapy and interferon treatment. J Cancer Res Ther. 2013;9:125\u20137.","journal-title":"J Cancer Res Ther"},{"key":"1395_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1097\/JTO.0b013e3181e2bc5d","volume":"5","author":"YH Kim","year":"2010","unstructured":"Kim YH, Mishima M, Miyagawa-Hayashino A. Treatment of pulmonary epithelioid hemangioendothelioma with bevacizumab. J Thorac Oncol. 2010;5:1107\u20138.","journal-title":"J Thorac Oncol"},{"key":"1395_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0873-2159(15)30198-7","volume":"15","author":"T Lopes","year":"2009","unstructured":"Lopes T, Clemente S, Feliciano A, Louren\u00e7o I, Costa A, Gil DJ. Pulmonary epithelioid hemangioendothelioma -rarity, diagnosis and treatment difficulties. Rev Port Pneumol. 2009;15:1167\u201374 (in Portuguese).","journal-title":"Rev Port Pneumol"},{"key":"1395_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/CCO.0b013e32833aaad4","volume":"22","author":"MS Park","year":"2010","unstructured":"Park MS, Ravi V, Araujo DM. Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma\/solitary fibrous tumor. Curr Opin Oncol. 2010;22:351\u20135.","journal-title":"Curr Opin Oncol"},{"key":"1395_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/annonc\/mds237","volume":"24","author":"M Agulnik","year":"2013","unstructured":"Agulnik M, Yarber JL, Okuno SH, von Mehren M, Jovanovic BD, Brockstein BE, et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013;24:257\u201363.","journal-title":"Ann Oncol"},{"key":"1395_CR19","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1002\/cncr.28109","volume":"14","author":"C Chevreau","year":"2013","unstructured":"Chevreau C, Le Cesne A, Ray-Coquard I, Italiano A, Cioffi A, Isambert N, et al. Sorafenib in patients with progressive epithelioid hemangioendothelioma. Cancer. 2013;14:2639\u201344.","journal-title":"Cancer"},{"key":"1395_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa1303989","volume":"369","author":"RJ Motzer","year":"2013","unstructured":"Motzer RJ, Hutson TE, Cella D, Reeves J, Hawkins R, Guo J, et al. Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N Engl J Med. 2013;369:722\u201331.","journal-title":"N Engl J Med"},{"key":"1395_CR21","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","volume":"379","author":"WT van der Graaf","year":"2012","unstructured":"van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, Casali PG, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2012;379:1879\u201386.","journal-title":"Lancet"},{"key":"1395_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/JTO.0b013e31816e2400","volume":"3","author":"L Belmont","year":"2008","unstructured":"Belmont L, Zemoura L, Couderc LJ. Pulmonary epithelioid haemangioendothelioma and bevacizumab. J Thorac Oncol. 2008;3:557\u20138.","journal-title":"J Thorac Oncol"},{"key":"1395_CR23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/JTO.0b013e31820b9e23","volume":"6","author":"A Mizota","year":"2011","unstructured":"Mizota A, Shitara K, Fukui T. Bevacizumab chemotherapy for pulmonary epithelioid hemangioendothelioma with severe dyspnea. J Thorac Oncol. 2011;6:651\u20132.","journal-title":"J Thorac Oncol"},{"key":"1395_CR24","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1752-699X.2010.00221.x","volume":"5","author":"A Lazarus","year":"2011","unstructured":"Lazarus A, Fuhrer G, Malekiani C, McKay S, Thurber J. Primary pleural epithelioid hemangioendothelioma (EHE)\u2013two cases and review of the literature. Clin Respir J. 2011;5:e1\u20135.","journal-title":"Clin Respir J"},{"key":"1395_CR25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1665-2681(19)31596-0","volume":"10","author":"F Salech","year":"2011","unstructured":"Salech F, Valderrama S, Nervi B, Rodriguez JC, Oksenberg D, Koch A, et al. Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up. Ann Hepatol. 2011;10:99\u2013102.","journal-title":"Ann Hepatol"},{"key":"1395_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/1752-1947-4-413","volume":"4","author":"C Raphael","year":"2010","unstructured":"Raphael C, Hudson E, Williams L, Lester JF, Savage PM. Successful treatment of metastatic hepatic epithelioid hemangioendothelioma with thalidomide: a case report. J Med Case Rep. 2010;4:413.","journal-title":"J Med Case Rep"},{"key":"1395_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/MPH.0b013e31816e22d1","volume":"30","author":"A Kassam","year":"2008","unstructured":"Kassam A, Mandel K. Metastatic hepatic epithelioid hemangioendothelioma in a teenage girl. J Pediatr Hematol Oncol. 2008;30:550\u20132.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1395_CR28","first-page":"462","volume":"11","author":"E B\u00f6lke","year":"2006","unstructured":"B\u00f6lke E, Gripp S, Peiper M, Budach W, Schwarz A, Orth K, et al. Multifocal epithelioid hemangioendothelioma: case report of a clinical chamaeleon. Eur J Med Res. 2006;11:462\u20136.","journal-title":"Eur J Med Res"},{"key":"1395_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1159\/000082932","volume":"67","author":"RC Mascarenhas","year":"2004","unstructured":"Mascarenhas RC, Sanghvi AN, Friedlander L, Geyer SJ, Beasley HS, Van Thiel DH. Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma. Oncology. 2004;67:471\u20135.","journal-title":"Oncology"},{"key":"1395_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11060-009-0017-z","volume":"97","author":"A Sumrall","year":"2010","unstructured":"Sumrall A, Fredericks R, Berthold A, Shumaker G. Lenalidomide stops progression of multifocal epithelioid hemangioendothelioma including intracranial disease. J Neurooncol. 2010;97:275\u20137.","journal-title":"J Neurooncol"},{"key":"1395_CR31","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.3748\/wjg.v20.i22.7049","volume":"20","author":"MC Pallotti","year":"2014","unstructured":"Pallotti MC, Nannini M, Agostinelli C, Leoni S, Di Scioscio V, Mandrioli A, et al. Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma. World J Gastroenterol. 2014;20:7049\u201354.","journal-title":"World J Gastroenterol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1395-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1395-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1395-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1395-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T13:36:20Z","timestamp":1691674580000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1395-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,13]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1395"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1395-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,13]]},"assertion":[{"value":"12 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"402"}}